{'Year': '2020', 'Month': 'Jun', 'Day': '01'}
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis.
Identifying blood-based biomarkers that predict treatment response in RA is a clinical priority. We investigated differential DNA methylation as a candidate biomarker of response for the first-line drug used in RA, MTX.